$OPGN 1.58 Hoping 2 See More Downside on Funding. But If They Figure Out The Super Bug The Gains Here Could Be Enormous. Merck & Co. venture arm backs superbug fighter OpGen in $10.3 million funding round http://www.bizjournals.com/…/merck-co-venture-arm-backs-sup… … via @WBJonline
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.